TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Miltenyi Biotec Norden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
155,494
|
150,846
|
129,619 |
| Financial expenses |
32
|
1
|
20 |
| Earnings before taxes |
14,259
|
10,920
|
12,241 |
| EBITDA |
16,731
|
13,128
|
13,532 |
| Total assets |
76,160
|
62,593
|
53,181 |
| Current assets |
70,215
|
54,534
|
45,458 |
| Current liabilities |
45,331
|
43,028
|
42,147 |
| Equity capital |
30,829
|
19,565
|
11,034 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
21
|
22
|
19 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.5%
|
31.3%
|
20.7% |
| Turnover per employee |
7,404
|
6,857
|
6,822 |
| Profit as a percentage of turnover |
9.2%
|
7.2%
|
9.4% |
| Return on assets (ROA) |
18.8%
|
17.4%
|
23.1% |
| Current ratio |
154.9%
|
126.7%
|
107.9% |
| Return on equity (ROE) |
46.3%
|
55.8%
|
110.9% |
| Change turnover |
4,648
|
21,227
|
24,855 |
| Change turnover % |
3%
|
16%
|
24% |
| Chg. No. of employees |
-1
|
3
|
1 |
| Chg. No. of employees % |
-5%
|
16%
|
6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.